Top-News
Pharmazeutika USA

Esperion Therapeutics Inc. News

Aktie
WKN:  A1W1SJ ISIN:  US29664W1053 US-Symbol:  ESPR
2,24 €
+0,051 €
+2,33%
19:35:53 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
113,72 Mio.
Marktkapitalisierung *
248,23 Mio. €
Streubesitz
30,57%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 15.01.2024

Esperion Therapeutics Inc. News

18.01.24 - PR Newswire
Thinking about buying stock in Phoenix Motor, Mereo BioPharma, Esperion Therapeutics, Adagene, or Advanced Micro Devices?
Thinking about buying stock in Phoenix Motor, Mereo BioPharma, Esperion Therapeutics, Adagene, or Advanced Micro Devices? PR Newswire
09.01.24 - PR Newswire
Thinking about buying stock in Grifols, Esperion Therapeutics, Rithm Capital, Applied Optoelectronics, or Seres Therapeutics?
Thinking about buying stock in Grifols, Esperion Therapeutics, Rithm Capital, Applied Optoelectronics, or Seres Therapeutics? PR Newswire
08.01.24 - PR Newswire
Thinking about buying stock in Cyclacel Pharmaceuticals, Broadcom, Qualcomm, Esperion Therapeutics, or Arena Group?
Thinking about buying stock in Cyclacel Pharmaceuticals, Broadcom, Qualcomm, Esperion Therapeutics, or Arena Group? PR Newswire
05.01.24 - PR Newswire
Thinking about buying stock in Safe & Green Development, Esperion Therapeutics, Ford Motor, Vertex Pharmaceuticals, or LifeMD?
Thinking about buying stock in Safe & Green Development, Esperion Therapeutics, Ford Motor, Vertex Pharmaceuticals, or LifeMD? PR Newswire
14.12.23 - PR Newswire
Thinking about buying stock in Processa Pharmaceuticals, Adobe Inc, Progressive Corp, Hanryu Holdings, or Esperion Therapeutics?
Thinking about buying stock in Processa Pharmaceuticals, Adobe Inc, Progressive Corp, Hanryu Holdings, or Esperion Therapeutics? PR Newswire
26.09.23 - PR Newswire
Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech?
Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech? PR Newswire
15.06.23 - PR Newswire
Thinking about trading options or stock in Inpixon, DatChat, Esperion Therapeutics, Verastem, or Vision Marine Technologies?
Thinking about trading options or stock in Inpixon, DatChat, Esperion Therapeutics, Verastem, or Vision Marine Technologies? PR Newswire
15.06.22 - PR Newswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Esperion Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Esperion Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire
10.03.22 - PR Newswire
Thinking about buying stock in Marqeta, Ion Geophysical, Northern Dynasty Minerals, Esperion Therapeutics, or Aemetis?
Thinking about buying stock in Marqeta, Ion Geophysical, Northern Dynasty Minerals, Esperion Therapeutics, or Aemetis? PR Newswire
03.12.21 - PR Newswire
Thinking about buying stock in DiDi Global, New Oriental Education, Longeveron, Carnival Corp, or Esperion Therapeutics?
Thinking about buying stock in DiDi Global, New Oriental Education, Longeveron, Carnival Corp, or Esperion Therapeutics? PR Newswire
01.02.21 - PR Newswire
Thinking about trading options or stock in Nektar Therapeutics, Pfizer, AstraZeneca, Vir Biotechnology, or Esperion Therapeutics?
Thinking about trading options or stock in Nektar Therapeutics, Pfizer, AstraZeneca, Vir Biotechnology, or Esperion Therapeutics? PR Newswire
18.02.20 - PR Newswire
Thinking about trading options or stock in Duke Energy, Esperion Therapeutics, Expedia, MSCI Inc, or Walmart?
Thinking about trading options or stock in Duke Energy, Esperion Therapeutics, Expedia, MSCI Inc, or Walmart? PR Newswire
24.04.19 - PR Newswire
Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors to Contact Law Firm for Possible Claims Against Officers and Directors
Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors to Contact Law Firm for Possible Claims Against Officers and Directors PR Newswire
02.04.19 - PR Newswire
Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-Cholesterol Lowering and Reduced hsCRP in Statin Intolerant Patients
Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-​Cholesterol Lowering and Reduced hsCRP in Statin Intolerant Patients PR ...
14.03.19 - PR Newswire
Bempedoic Acid Study 1 Results Published in The New England Journal of Medicine Demonstrates Significant LDL-Cholesterol Lowering and Reduced Marker of Underlying Cardiovascular Inflammation, with a Similar Tolerability to Placebo
Bempedoic Acid Study 1 Results Published in The New England Journal of Medicine Demonstrates Significant LDL-​Cholesterol Lowering and Reduced Marker of Underlying ...
07.01.19 - PR Newswire
Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet
Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet PR Newswire
05.06.18 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury System
Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, ...
02.05.18 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Esperion Therapeutics, Inc. - ESPR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Esperion Therapeutics, Inc. - ESPR PR Newswire
02.05.18 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Esperion Therapeutics, Inc. (ESPR)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Esperion Therapeutics, Inc. (ESPR) PR Newswire
14.03.18 - The Motley Fool
Regeneron zielt auf Amgen und Esperion Therapeutics ab
Fast ein Jahr nachdem der Wettbewerber Amgen (WKN:867900) gemeldet hatte, dass das cholesterinsenkende Medikament Repatha das Risiko von schweren unerwünschten ...

Newssuche

Videos

03.07.24 +3,08%
Technical Trading: Bund Future Long Chance
Bund Future Long Typ: Turbo Open End WKN: VM3CG4 Hebel: 7,32 Laufzeit: OpenEnd Einstieg: Market ... Mehr »